(Q34489850)

2 August 2017

1 reference

title

Novel chelating agents for potential clinical applications of copper (English)

1 reference

2 August 2017

0 references

Dangshe Ma

1

1 reference

2 August 2017

Francis Lu

2

1 reference

2 August 2017

Terrish Overstreet

3

1 reference

2 August 2017

Diane E Milenic

4

1 reference

2 August 2017

Martin W Brechbiel

5

1 reference

2 August 2017

publication date

1 January 2002

1 reference

Nuclear Medicine and Biology

2 August 2017

published in

1 reference

2 August 2017

volume

29

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

91-105

1 reference

Synthesis and characterization of the tetraazamacrocycle 4,10-dimethyl-1,4,7,10-tetraazacyclododecane-1,7-diacetic acid (H2Me2DO2A) and of its neutral copper(II) complex [Cu(Me2DO2A)]. A new 64Cu-labeled macrocyclic complex for positron emission tomo

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Copper radionuclides and radiopharmaceuticals in nuclear medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for (225)Ac radioimmunotherapy applications

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Serum stability of 67Cu chelates: comparison with 111In and 57Co

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Tricationic Metal Complexes ([ML][NO3]3, M = Ga, In) ofN,N‘,N‘‘-Tris(2-pyridylmethyl)-cis-1,3,5-triaminocyclohexane: Preparation and Structure

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

The in vivo behavior of copper-64-labeled azamacrocyclic complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Syntheses and characterizations of metal complexes derived from cis,cis-1,3,5-triaminocyclohexane-N,N',N"-triacetic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

High purity production and potential applications of copper-60 and copper-61

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Efficient production of high specific activity 64Cu using a biomedical cyclotron

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Copper(II) complexes of novel N-alkylated derivatives of cis,cis-1,3,5-triaminocyclohexane. 1. Preparation and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Effect of metal size on coordination geometry of N,N′,N″-tris(2-pyridylmethyl)-cis,cis-1,3,5-triaminocyclohexane: synthesis and structure of [MIIL](ClO4)2 (M=Zn, Cd and Hg)

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Copper incorporation into superoxide dismutase in Menkes lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Identification of an apo-superoxide dismutase (Cu,Zn) pool in human lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Comparison of Four Bifunctional Chelates for Radiolabeling Monoclonal Antibodies with Copper Radioisotopes: Biodistribution and Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

Determination of iron, cobalt, copper, zinc, rubidium, molybdenum, and cesium in human serum by inductively coupled plasma mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900287-6

7 January 2021

10.1016/S0969-8051(01)00287-6

Identifiers

DOI

1 reference

2 August 2017

1 reference